Citigroup’s GeoVax Labs GOVX Stock Holding History

Citigroup’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10	Closed	-$292	–	6097
2026 Q2	$292	Buy	+10	New	+$365	﹤0.01%	5475
2025 Q4	–	Sell	-16	Closed	-$4.59K	–	6206
2025 Q3	$4.59K	Buy	16 +9	+129%	+$3.78K	﹤0.01%	5254
2025 Q2	$3.55K	Buy	+7	New	+$4.19K	﹤0.01%	5319
2025 Q1	–	Sell	-8	Closed	-$12.4K	–	5728
2024 Q4	$12.4K	Sell	8 -11	-58%	-$15.3K	﹤0.01%	5345
2024 Q3	$28K	Buy	+19	New	+$38.3K	﹤0.01%	5130
2022 Q2	–	Hold	0	–	-$4K	–	6391
2022 Q1	–	Hold	0	–	–	–	5888

Other funds holding GOVX

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

Citigroup's GOVX Position: Q3 2026 in Review

Citigroup sold out of GeoVax Labs (GOVX) in Q3 2026, closing a stake of 10 shares — an estimated $292 sold.

Citigroup first reported a position in GOVX in Q3 2024 and held it in 5 quarters. The position peaked at $28K in Q3 2024. 4 funds tracked by Wall St. Rank hold GOVX as of Q3 2026.

Citigroup reported no remaining GeoVax Labs position as of Q3 2026 after selling out during the quarter.
Citigroup sold 10 GeoVax Labs shares in Q3 2026, an estimated $292.
Citigroup first reported a position in GeoVax Labs in Q3 2024 and held it in 5 quarters.
Citigroup's GeoVax Labs position peaked at $28K in Q3 2024.
4 funds tracked by Wall St. Rank held GeoVax Labs as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.